Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. [electronic resource]
Producer: 20040514Description: 183-94 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Docetaxel
- Fatigue
- Female
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Pain
- Quality of Life
- Salvage Therapy
- Survival Analysis
- Taxoids -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.